Expert-level biomaterials covering biocompatibility, metals, ceramics, and polymers for medical implants, surface modification, host response, and regulatory considerations.
Definition: ability of material to perform with appropriate host response in specific application. ISO 10993: biological evaluation framework, risk-based test selection. Cytotoxicity: cell viability in extract or direct contact with material. Sensitization: delayed hypersensitivity response, Ni and Co most common metal sensitizers. Systemic toxicity: response to extracts, repeated dose and subchronic studies.
Stainless steel: 316L grade, austenitic, low carbon, passivating oxide layer. Cobalt chromium: excellent wear resistance, used in joint replacements. Titanium alloys: Ti-6Al-4V most common, low modulus, excellent osseointegration. Corrosion: crevice corrosion and fretting at modular interfaces concern. Wear particles: metal ions and particles cause adverse tissue reactions.
Alumina: hip bearing surface, excellent wear resistance, brittle. Zirconia: tougher than alumina, white color, dental applications. Hydroxyapatite: bone mineral composition, promotes osseointegration as coating. Bioactive glass: bonds to bone through surface reaction layer.
PLA and PGA: hydrolytic degradation, tunable by copolymer ratio. PLGA: most common degradable polymer for drug delivery and scaffolds. Degradation products: must be non-toxic and cleared by normal metabolic pathways. Matching degradation to healing: scaffold must persist until tissue replaces it.
| Pitfall | Fix |
|---|---|
| Assuming biocompatibility from material class alone | Test actual device materials and geometry |
| Wrong sterilization for polymer | EO or radiation affects polymer properties differently |
| Ignoring protein adsorption | Protein layer mediates cell-material interaction |
| Insufficient extractables testing | Real implant conditions differ from standard extracts |